Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02419183 · ClinicalTrials.gov registry record

A Study of a Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR) in Participants With Mild Cognitive Impairment

A clinical trial of Mild Cognitive Impairment, sponsored by Janssen Research & Development.

Completed
Registry status
153
Enrollment target
2
Study locations

NCT02419183 is a study of Mild Cognitive Impairment that has completed, run by Janssen Research & Development. The registered enrollment target is 153 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02419183, a study of Mild Cognitive Impairment, has completed, sponsored by Janssen Research & Development.

COMPLETED
Registry status
153 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to evaluate the psychometric properties of a Self-administered Memory Screening Test with Automated Reporting (SAMSTAR) adapted from the Rey Auditory Verbal Learning Test (RAVLT) in normal control (NC) participants and participants with Mild Cognitive Impairment (MCI) against a standard version of the RAVLT test, administered by an examiner under the same conditions.

Conditions Studied

Mild Cognitive Impairment

Interventions

  • OTHER SAMSTAR
  • OTHER RAVLT

Study Locations (2)

North Carolina

  • - Chapel Hill
  • - Durham

Trial Details

FieldValue
Enrollment Target 153 participants
Start Date 2015-05
Est. Completion 2016-03

Sponsor

Janssen Research & Development

593 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02419183

The ClinicalTrials.gov registry entry for NCT02419183 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (88% lower). The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which SAMSTAR is the first listed.

NCT02419183 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02419183 about?

NCT02419183 is a clinical study titled "A Study of a Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR) in Participants With Mild Cognitive Impairment". The purpose of this study is to evaluate the psychometric properties of a Self-administered Memory Screening Test with Automated Reporting (SAMSTAR) adapted from the Rey Auditory Verbal Learning Test (RAVLT) in normal control (NC) participants and participants with Mild Cognitive Impairment (MCI) ag...

What is the current status of trial NCT02419183?

This trial is currently completed. The enrollment target is 153 participants. The study started on 2015-05. Estimated completion is 2016-03.

What conditions does trial NCT02419183 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment.

What interventions are being tested in trial NCT02419183?

The interventions under investigation include: SAMSTAR (OTHER), RAVLT (OTHER).

Who is sponsoring clinical trial NCT02419183?

This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02419183 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Mild Cognitive Impairment

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.